Firm Touts Diversity In Bid To Lead COVID Drug Claims Suit

By Sarah Jarvis · November 9, 2022, 4:47 PM EST

Faruqi & Faruqi LLP has touted its minority and woman ownership in its bid to lead an investor suit against Ampio Pharmaceutical Inc. over its executives' claims about a COVID-19 drug, while...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Wang et al v. Ampio Pharmaceuticals, Inc. et al

Case Number

1:22-cv-02105

Court

Colorado

Nature of Suit

Securities, Commodities, Exchange

Date Filed

August 17, 2022